Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Arbutus Biopharma Corp. buy melinda

Start price
€4.19
16.10.18 / 50%
Target price
€6.31
02.11.18
Performance (%)
13.55%
End price
€4.76
02.11.18
Summary
This prediction ended on 02.11.18 with a price of €4.76. The BUY prediction by melinda finished with a performance of 13.55%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Arbutus Biopharma Corp. 0.693% 0.693% 10.847% 12.905%
iShares Core DAX® 0.476% -0.039% 13.342% 17.330%
iShares Nasdaq 100 1.290% 0.504% 40.099% 50.534%
iShares Nikkei 225® 1.300% -2.135% 19.861% 4.937%
iShares S&P 500 0.829% 0.193% 29.756% 43.432%

According to melinda what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Arbutus Biopharma Corp. diskutieren
Prediction Buy
Perf. (%) 13.55%
Target price 6.314
Change
Ends at 02.11.18

SecteurProduits pharmaceutiques Agenda 08/11 Publication de résultats



Métier
Logo Arbutus Biopharma Corp
Develops drugs to improve the treatment of cancer

Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection.

The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.

Nombre d'employés : 130 personnes.



Prediction Buy
Perf. (%) 13.55%
Target price 6.314
Change
Ends at 02.11.18

(Vom Mitglied beendet)

Stopped prediction by melinda for Arbutus Biopharma Corp.

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.20
24.12.23
-
24.12.24
1.36%
06.01.24

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.03
08.07.23
-
08.07.24
-18.91%
26.11.23

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.08
20.05.20
€4.50
04.11.21
56.99%
05.11.21

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.14
06.01.20
-
20.05.20
-33.64%
20.05.20

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€1.73
03.06.19
€2.35
20.06.19
36.98%
20.06.19

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€6.55
21.10.17
€7.50
27.12.17
-26.72%
27.12.17

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€5.91
21.10.17
€6.77
27.12.17
-26.72%
27.12.17

Could be worthwhile Investment >10% per year